MedTech (NASDAQ:MTAC) terminated its combination with surgical technology company Memic this morning after adjourning it’s scheduled meeting to complete yesterday to this morning at 11AM.
Yesterday’s meeting received sufficient turnout and affirmative votes, but adjourned without finalizing any business. A number of SPAC deals have fallen through in the current climate of high redemptions and while MedTech did not disclose redemption figures, they were likely the cause of the breakup.
The parties’ combination agreement required MedTech to maintain at least $250 million in cash available and that less than 50% of its trust be redeemed by shareholders. Only five of the 30 votes reported by SPACs so far this year have seen redemptions under 50% and that includes extension votes, which typically see lower figures.
Nonetheless, more optimistic deal terms were not unreasonable when the $655 million combination was announced on August 13, 2021. MedTech also supplemented the transaction with a $76 million PIPE, but adding to PIPEs has become increasingly difficult in the present environment.
MedTech will continue to seek out a combination and has time with transaction deadline set for December 22, 2022.
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...